Improving drug design for Alzheimer's disease using advanced computational methods
Tackling Multifaceted Drug Design Problems with Lambda Dynamics Based Technologies
['FUNDING_OTHER'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-10864994
This study is looking for better ways to find new medications for Alzheimer's disease by using computer techniques to see how potential drugs work with the proteins in the brain, which could help create safer and more effective treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INDIANA UNIVERSITY INDIANAPOLIS (nih funded) |
| Locations | 1 site (INDIANAPOLIS, UNITED STATES) |
| Trial ID | NIH-10864994 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the drug discovery process for Alzheimer's disease by utilizing advanced computational techniques known as lambda dynamics. These methods allow researchers to simulate and analyze how potential drug candidates interact with target proteins, significantly reducing the time and cost associated with traditional drug development. By exploring various chemical modifications and their effects on drug binding, the research aims to identify more effective treatments for Alzheimer's disease. Patients may benefit from the development of new drugs that are optimized for better efficacy and safety.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other types of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective drugs for Alzheimer's disease, improving patient outcomes.
How similar studies have performed: Previous research using computational methods in drug design has shown promising results, indicating that this approach could lead to significant advancements in treatment options.
Where this research is happening
INDIANAPOLIS, UNITED STATES
- INDIANA UNIVERSITY INDIANAPOLIS — INDIANAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VILSECK, JONAH — INDIANA UNIVERSITY INDIANAPOLIS
- Study coordinator: VILSECK, JONAH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease